Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

21 January 2020

Antibiotikaresistenzen: Zu viel vom Falschen

Thomas Trappe of Tagesspiegel writes about the launch of the new Antimicrobial Resistance Benchmark during the 2020 World Economic Forum in Davos.

Direct links

Read the full article

The article begins with a quote from Jayasree K Iyer, Executive Director of the Access to Medicine Foundation:

We are losing ground both with the new antibiotics and with those that have existed for a long time.

The article then dives into the results of the 2020 Antimicrobial Resistance Benchmark, covering topics like antibacterial R&D, forgotten antibiotics progress in responsible promotion, and tracking the spread of resistance. It highlights the top performing companies in these areas. 

The article states that Iyer hopes for support from the German Chancellor to help tackle AMR. Angela Merkel, says Iyer, will meet the heads of several pharmaceutical companies at the World Economic Forum currently taking place in Davos: Here, she can urge them to invest more in the development of antibiotics and the fight against antibiotic resistance.

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved